Latest Breaking News On - Ontario cancer institute toronto - Page 1 : comparemela.com

Dr. Simon Plyte will help Biomunex accelerate preclinical and early clinical development of bi- and multi-specific antibodies in the treatment of cancer and ensure evolution of the BiXAb® platformDr. Plyte will also join the scientific advisory.

United statesFrance generalUnited kingdomSimon plytePierre emmanuel gerardInstitut curieBoehringer ingelheim biberachOntario cancer institute torontoOlivier lantz institut curie clinical immunology laboratoryBoehringer ingelheimUniversity of kielUniversity of portsmouthLudwig institute for cancer research londonMatthias peipp head of division antibodyBiomunex pharmaceuticalsNerviano medical sciences